Collagen Supplements for Skin: The Numbers Behind the Claims

A 2023 review of 26 randomized trials involving 1,721 participants reported improved skin hydration and elasticity with oral collagen supplements. An overview of the clinical evidence summarizes those findings alongside a later review that examined results by study quality and funding.

For a woman deciding whether collagen deserves a place in her budget, the useful question is more specific than whether it “works.” Which skin outcome improved? How was that outcome measured? And how closely does the evidence match the claim on the product?

What did collagen supplement trials actually measure?

The 2023 systematic review brought together randomized controlled trials of oral hydrolyzed collagen. Its main pooled outcomes were instrument-measured skin hydration and elasticity. Measurements came from areas including the cheek and forearm, as well as the forehead.

That detail matters when reading the results. A hydration reading describes the outcome captured by that measurement. An elasticity assessment examines a different skin property. Wrinkle appearance is another endpoint again, even when advertising groups them together under a broad promise of younger-looking skin.

The review also included individual trials with tissue-related assessments. Its study table listed a 2014 trial involving 107 women that measured wrinkles alongside biopsies and markers such as procollagen. Other listed measures included elastin and fibrillin, as well as dermal collagen or collagen content.

So the research was not limited to questionnaires about whether participants liked their skin. It included instrument readings and some tissue-related measurements. Understanding which type of evidence supports a particular claim is the starting point for interpreting the numbers.

How large were the reported improvements?

The 2023 review reported statistically significant pooled improvements in hydration and elasticity. The reported effect sizes were 0.63 for hydration and 0.72 for elasticity. These are effect-size statistics, not percentage improvements in skin appearance.

The same review found a more favorable pooled hydration result in studies lasting longer than eight weeks than in shorter studies. That was a comparison across study groups rather than a demonstrated timetable for an individual consumer.

A separate 2025 meta-analysis pooled 23 randomized trials involving 1,474 participants. Its overall analysis found statistically significant improvements in hydration and elasticity, along with wrinkles.

Read together, those overall findings explain why favorable collagen claims continue to circulate. Both reviews found positive pooled results. The next question is how those results held up when the researchers examined the evidence more closely.

Where do the numbers become less certain?

Did the trials test comparable products?

The 2023 review documented differences in collagen source and dose, as well as study duration and measurement methods. Pooling those trials provides a summary of the included research. It does not make the tested formulations interchangeable.

Some individual studies enrolled fewer than 40 people. The review also identified missing outcome data in 13 trials and deviations from the intended intervention in seven. These concerns affect confidence in the combined findings, even when the overall result reaches statistical significance.

Did funding and study quality change the result?

In the 2025 review, benefits were not statistically significant in the high-quality-study subgroup or in studies without pharmaceutical-company funding. Its authors concluded that clinical evidence did not support collagen supplements to prevent or treat skin aging.

That conclusion needs to be read alongside the favorable overall analysis. The subgroup findings are a reason to scrutinize the evidence, not proof that every collagen product is ineffective. They show why a pooled result alone is an incomplete basis for a purchasing claim.

Funding also needs careful interpretation. The 2023 review reported hospital funding and declared no conflicts. A disclosure is useful information, but study methods and the match between the evidence and the claim still need examination.

Did the studies establish lasting facial collagen rebuilding?

The 2023 trials lasted 2 to 12 weeks. That follow-up supports discussion of short-term outcomes, not conclusions about years of use or what happens after supplementation stops.

The review’s principal pooled endpoints were hydration and elasticity. It did not pool a direct measure of rebuilt facial collagen. Individual biopsy or collagen-marker findings belong to their specific studies and do not automatically establish a visible or durable effect across consumer products.

These are separate questions: whether an instrument detects a change, whether someone notices a difference and whether facial tissue has changed in a lasting way. The evidence should not move from one claim to another without the corresponding measurements.

What should these findings mean for a purchase decision?

The most useful approach is to make the product claim answerable. “Supports skin” is broad. A claim about measured hydration is more specific and can be compared with the endpoint a trial actually assessed.

For a health-conscious woman considering the ongoing expense, the following checks help connect the research to the purchase:

• Identify the promised outcome. Look for a clear distinction between hydration and elasticity, wrinkle appearance or tissue-related changes.
• Match the formulation. Check whether the research concerns the same named ingredient or formulation being sold.
• Read beyond the headline result. Look for participant numbers and the comparator, along with the measured endpoint and funding disclosure.
• Check the study period. Establish when outcomes were assessed rather than treating a study’s duration as a personal deadline for results.
• Ask what the reported change represents. An effect-size statistic should be presented as such, rather than rewritten as a percentage improvement in appearance.

These are evidence checks, not a supplement protocol. They help establish whether the supporting research is relevant enough to justify the money and attention a product requires. Younell’s guide to interpreting collagen trial results offers broader context for that assessment.

For someone whose main goal is a visible facial change, the most relevant evidence would directly assess that outcome. Our discussion of measured hydration versus noticeable appearance examines that distinction in more detail.

A reasonable purchasing standard is that the claim should fit the evidence, rather than requiring the reader to fill in missing steps. Questions about whether a supplement fits personal health circumstances belong with a qualified healthcare professional.

What should we watch next in collagen research?

The next phase of the scientific discussion around hydrolyzed collagen meta-analyses needs stronger underlying trials. The 2023 review’s authors called for larger randomized studies. That remains a useful direction for the field.

Future research would be more informative with clearly identified formulations and transparent funding. It also needs outcomes that connect instrument readings with changes people can notice. Longer follow-up should establish whether any benefits persist and what happens after supplementation ends.

The central question is no longer simply whether a pooled analysis can produce a favorable result. It is whether well-designed studies can show a meaningful and lasting benefit for a defined product. That is the evidence needed to make collagen claims more dependable.

Sources

1. Collagen - About Supplements
2. Hydrolyzed Collagen for Skin Aging Meta‐Analyses Are ...